Amneal Pharmaceuticals LLC
Amneal Pharmaceuticals LLC, a prominent player in the pharmaceutical industry, is headquartered in the United States. Founded in 2002, the company has established itself as a leader in the development and manufacturing of generic and specialty pharmaceuticals, focusing on areas such as pain management, neurology, and infectious diseases. With a robust portfolio of core products, Amneal is recognised for its commitment to quality and innovation, offering unique formulations that meet the evolving needs of patients and healthcare providers. The company has achieved significant milestones, including strategic partnerships and expansions into key operational regions, solidifying its market position. Amneal Pharmaceuticals continues to drive advancements in healthcare, making a meaningful impact on patient lives through its diverse range of therapeutic solutions.
DitchCarbon Score
How does Amneal Pharmaceuticals LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Amneal Pharmaceuticals LLC's score of 5 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Amneal Pharmaceuticals LLC's reported carbon emissions
Amneal Pharmaceuticals LLC, headquartered in the US, currently does not have publicly available data regarding its carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This absence of data suggests that Amneal Pharmaceuticals may still be in the early stages of formalising its climate commitments or reporting on its environmental impact. In the pharmaceutical industry, companies are increasingly recognising the importance of sustainability and are often encouraged to establish clear targets for reducing greenhouse gas emissions across all scopes (Scope 1, 2, and 3). As the industry evolves, it is anticipated that Amneal Pharmaceuticals will develop and disclose its climate strategies and emissions data in the future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Amneal Pharmaceuticals LLC is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
